Zhejiang Medicine Co Ltd (600216) — Financial Flexibility Index
Zhejiang Medicine Co Ltd (600216) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥770.79 Million (operating CF CN¥690.77 Million minus capex CN¥80.03 Million) represents 0% of total liabilities (CN¥2.92 Billion). Also explore Zhejiang Medicine Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Medicine Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Zhejiang Medicine Co Ltd across 28 annual periods. Check 600216 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Medicine Co Ltd. For the full company profile including market capitalisation, see market cap of Zhejiang Medicine Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥2.33 Billion | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +18.9% |
| 2024 | 0.65x | CN¥1.91 Billion | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +27.5% |
| 2023 | 0.51x | CN¥1.43 Billion | CN¥634.31 Million | CN¥2.79 Billion | ▼ -6.8% |
| 2022 | 0.55x | CN¥1.50 Billion | CN¥520.60 Million | CN¥2.72 Billion | ▼ -11.3% |
| 2021 | 0.62x | CN¥2.08 Billion | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -14.6% |
| 2020 | 0.73x | CN¥1.79 Billion | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +49.9% |
| 2019 | 0.48x | CN¥1.02 Billion | CN¥447.25 Million | CN¥2.11 Billion | ▼ -6.8% |
| 2018 | 0.52x | CN¥1.02 Billion | CN¥579.91 Million | CN¥1.96 Billion | ▼ -2.6% |
| 2017 | 0.53x | CN¥1.07 Billion | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.3% |
| 2016 | 0.39x | CN¥717.90 Million | CN¥336.14 Million | CN¥1.82 Billion | ▼ -22.6% |
| 2015 | 0.51x | CN¥831.50 Million | CN¥106.54 Million | CN¥1.63 Billion | ▼ -56.8% |
| 2014 | 1.18x | CN¥1.54 Billion | CN¥549.90 Million | CN¥1.31 Billion | ▼ -31.2% |
| 2013 | 1.71x | CN¥1.84 Billion | CN¥655.09 Million | CN¥1.08 Billion | ▼ -15.9% |
| 2012 | 2.04x | CN¥1.75 Billion | CN¥807.49 Million | CN¥860.73 Million | ▲ +29.4% |
| 2011 | 1.57x | CN¥1.26 Billion | CN¥912.75 Million | CN¥798.63 Million | ▼ -16.7% |
| 2010 | 1.89x | CN¥1.46 Billion | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.9% |
| 2009 | 1.59x | CN¥1.62 Billion | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +73.4% |
| 2008 | 0.92x | CN¥1.33 Billion | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +373.9% |
| 2007 | 0.19x | CN¥381.05 Million | CN¥227.67 Million | CN¥1.97 Billion | ▼ -19.3% |
| 2006 | 0.24x | CN¥419.49 Million | CN¥169.51 Million | CN¥1.75 Billion | ▼ -3.7% |
| 2005 | 0.25x | CN¥367.08 Million | CN¥25.14 Million | CN¥1.48 Billion | ▲ +17.6% |
| 2004 | 0.21x | CN¥252.40 Million | CN¥107.60 Million | CN¥1.19 Billion | ▲ +11.4% |
| 2003 | 0.19x | CN¥197.57 Million | CN¥66.20 Million | CN¥1.04 Billion | ▼ -19.3% |
| 2002 | 0.24x | CN¥236.94 Million | CN¥23.13 Million | CN¥1.01 Billion | ▲ +2.9% |
| 2001 | 0.23x | CN¥218.69 Million | CN¥98.25 Million | CN¥956.66 Million | ▲ +36.5% |
| 2000 | 0.17x | CN¥134.28 Million | CN¥10.58 Million | CN¥801.61 Million | ▲ +419.4% |
| 1999 | 0.03x | CN¥35.32 Million | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -86.3% |
| 1998 | 0.23x | CN¥183.80 Million | CN¥57.72 Million | CN¥782.87 Million | — |